We're buying more of this life sciences stock after an earnings-driven decline
The stock is under pressure in early trading due to uncertainty around the recovery in a key business. Source link: https://www.cnbc.com/2023/10/24/were-buying-more-of-this-life-sciences-stock-after-an-earnings-driven-decline.html